Page last updated: 2024-10-28

hydroxyurea and Hodgkin Disease

hydroxyurea has been researched along with Hodgkin Disease in 12 studies

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research Excerpts

ExcerptRelevanceReference
"From 23 patients with advanced non-Hodgkin lymphomas of a high malignancy 11 received a therapy with CVPP scheme; 2 of them came into a complete remission and 3 of them into a partial one."2.65[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study]. ( Anger, G; Fink, R; Höche, D, 1980)
"Hydroxyurea (HU) is an oral drug that ameliorates the clinical course of sickle cell anemia by increasing the levels of fetal hemoglobin and decreasing the adhesion of red cells to endothelium."1.31Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea. ( Menegas, D; Moschovi, M; Nicolaidou, P; Nikolaidou, P; Psychou, F; Tsangaris, GT; Tzortzatou-Stathopoulou, F, 2001)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19909 (75.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couronné, L1
Schneider, P1
de Montalembert, M1
Dumesnil, C1
Lahary, A1
Vannier, JP1
Schmidt-Wolf, IG1
Rockstroh, JK1
Schlegel, U1
Pels, H1
Weiss, R1
Huhn, D1
FERNBACH, DJ1
DAVIS, P1
KRAKOFF, IH1
SAVEL, H1
MURPHY, ML1
Höche, D1
Fink, R1
Anger, G1
Moschovi, M1
Psychou, F1
Menegas, D1
Tsangaris, GT1
Tzortzatou-Stathopoulou, F1
Nicolaidou, P1
Nikolaidou, P1
Klein, HO1
Adler, D1
Doering, M1
Klein, PJ1
Lennartz, KJ1
Pouillart, P1
Schwarzenberg, L2
Mathé, G2
Schneider, M2
Jasmin, C1
Hayat, M1
Weiner, R1
de Vassal, F1
Amiel, JL2
Beyer, HP1
Fajbisowicz, S1
Carter, SK1
Cattan, A1
Schlumberger, JR1
Stutzman, L1

Reviews

2 reviews available for hydroxyurea and Hodgkin Disease

ArticleYear
New aspects in the treatment of AIDS-related lymphoma.
    European journal of medical research, 2002, Jul-24, Volume: 7, Issue:7

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Hodgkin Disease; Humans; Hydroxyurea; Immunotherapy

2002
An overview of the status of the nitrosoureas in other tumors.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br

1973

Trials

2 trials available for hydroxyurea and Hodgkin Disease

ArticleYear
[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
    Folia haematologica (Leipzig, Germany : 1928), 1980, Volume: 107, Issue:1

    Topics: Bleomycin; Cell Division; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Hodgkin D

1980
Combined radiotherapy and chemotherapy of lymphomas and other cancers.
    Cancer research, 1971, Volume: 31, Issue:11

    Topics: Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Fluorouracil; Follow-Up Studies; Hematopoi

1971

Other Studies

8 other studies available for hydroxyurea and Hodgkin Disease

ArticleYear
Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea.
    Annals of hematology, 2009, Volume: 88, Issue:6

    Topics: Adolescent; Anemia, Sickle Cell; Hodgkin Disease; Humans; Hydroxyurea; Male

2009
PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Adolescent; Antineoplastic Agents; Child; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukemia; Neop

1964
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukopenia; Lymphoma; Lymphoma, L

1964
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leu

1964
Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea.
    Pediatric hematology and oncology, 2001, Volume: 18, Issue:6

    Topics: Anemia, Sickle Cell; beta-Thalassemia; Bone Marrow Transplantation; Child; Combined Modality Therapy

2001
Investigations on pharmacologic induction of partial synchronization of tumor cell proliferation: its relevance for cytostatic therapy.
    Cancer treatment reports, 1976, Volume: 60, Issue:12

    Topics: Adolescent; Adult; Aged; Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cyclophosphamide; Drug Ad

1976
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
    La Nouvelle presse medicale, 1972, Jun-24, Volume: 1, Issue:26

    Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; D

1972
[Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1

    Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Hydroxyurea; Leukemia; L

1968